Samsung Biologics now ready for big M&A in $205b o
Post# of 148172
(Total Views: 657)
Posted On: 08/24/2021 11:41:41 AM
Samsung Biologics now ready for big M&A in $205b overall Samsung capital spending plan
"There will be two new plants opened by Samsung Biologics and Bioepis, according to the Korea JoongAng Daily. That will mark the fifth and sixth plants the company owns, as it pushes to become the biggest biosimilar contract manufacturer in the world. A spokesperson for the company told the Korean paper that it is on the lookout for “M&As of a significant size.”"
https://endpts.com/as-leader-is-freed-from-pr...ing-spree/
"There will be two new plants opened by Samsung Biologics and Bioepis, according to the Korea JoongAng Daily. That will mark the fifth and sixth plants the company owns, as it pushes to become the biggest biosimilar contract manufacturer in the world. A spokesperson for the company told the Korean paper that it is on the lookout for “M&As of a significant size.”"
https://endpts.com/as-leader-is-freed-from-pr...ing-spree/
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼